6640--KIT, 10-TEST, MRSA NXG, IVD, GX
Veterans Affairs · 248-NETWORK CONTRACT OFFICE 8 (36C248)
Capture briefs (a one-page, shareable copy of this page) are part of Pro. The CSV here holds the notice, its timeline and past awards.
Where this opportunity stands
Every notice posted under solicitation 36C24826Q0764 in this department, oldest first.
Next steps for this stage
Standard steps for the notice type; not advice about this buyer.
- Decide bid or no bid before the response deadline.
- Look at the past winners for likely competitors and teaming partners.
- Follow the opportunity to hear about amendments and the award.
Who won similar work
6 award notices on SAM.gov in the last 24 months. Matched by: Same office (248-NETWORK CONTRACT OFFICE 8 (36C248)), same product/service code (PSC) 6640 and NAICS 334516.
Single-winner award sizes (6): middle half $378K to $3.3M, median $1.7M; range $83K to $3.6M.
| Winner | Awards | Value | Last |
|---|---|---|---|
| POLYMEDCO CANCER DIAGNOSTIC PRODUCTS LLC | 2 | $4.2M | Apr 16, 2026 |
| SEBIA, INC. | 1 | $3.6M | May 4, 2026 |
| Fisher Scientific Company · $TMO · $42.9B | 1 | $2.7M | Mar 31, 2026 |
| CEPHEID SUNNYVALE 94089 | 1 | $282K | Apr 2, 2025 |
| FRANKLIN YOUNG INTERNATIONAL, INCORPORATED | 1 | $83K | Oct 1, 2025 |
Value counts single-winner awards. "Shared" awards are multiple-award contracts that list every winner with the same total ceiling; that ceiling is not one company's win, so it is not added in. Revenue next to a ticker is the company's last annual revenue from its 10-K.
- $TMO reported $42.9B revenue in FY2025. The median single-winner award in these 6 past awards, $1.7M, is under 0.1% of that. 10-K
One award's total value against one year of revenue; many awards are paid over several years.
- May 4, 2026SEBIA, INC.$3.6M6640--VISN 8 Electrophoresis TestingNo listed company matched (Materiality N/A)
- Apr 16, 2026POLYMEDCO CANCER DIAGNOSTIC PRODUCTS LLC$3.5M6640--VISN 8 Mail FIT KitsNo listed company matched (Materiality N/A)
- Mar 31, 2026Fisher Scientific Company$2.7M6640--Allergy and Autoimmune Disease (TAM and BP)Materiality: <0.01% of $TMO revenue (Low) SEC
- Oct 1, 2025FRANKLIN YOUNG INTERNATIONAL, INCORPORATED$83K6640--JAK2 Molecular ReagentsNo listed company matched (Materiality N/A)
- May 9, 2025POLYMEDCO CANCER DIAGNOSTIC PRODUCTS LLC$666K6640--FY25: Automated Immunochemical Fecal Occult Blood Test (IFOBT)No listed company matched (Materiality N/A)
- Apr 2, 2025CEPHEID SUNNYVALE 94089$282K6640--FY25 Q3 Micro Molecular Testing (VA-25-00029953)No listed company matched (Materiality N/A)
Materiality: one award's value as a share of the winner's revenue over the latest 12 months in its SEC filings (or its last fiscal year, as noted when you point at it). Low under 1%, Medium 1 to 5%, High 5% or more. Many awards are paid over several years, so this overstates a single year's share.
Competitive landscape
For the 5 most frequent past winners above. Lobbying is matched by the company's exact name or exact ticker; agencies are as named on the filings.
- 1 of these past winners lobbied Veterans Affairs, Dept of (VA) since 2024 (1 filings)
- 0 of their lobbyists list a past Veterans Affairs, Dept of (VA) job
- $40K from their corporate PACs since 2024 to members of House Committee on Appropriations, House Committee on Veterans' Affairs, Senate Committee on Appropriations, Senate Committee on Veterans' Affairs
- 0 foreign-agent (FARA) registrations
Policy around it
Bills the past winners named while lobbying this agency's issues, rules from the department, and executive orders that name the agency, last 12 months.
- 7 bills named on the past winners' lobbying filings
- 25 rules from the department in the last 12 months
- 0 executive orders naming the agency in the last 12 months
Market
For past winners matched exactly to a listed company. Insider trades are open-market buys and sells (Form 4) in the last 90 days, shown as facts; our own study found insiders do not reliably buy ahead of awards. A sale marked 10b5-1 was made under a trading plan set up in advance.
- 1 of the past winners are listed companies
- 0 insider buys and 7 insider sells at them in the last 90 days
Sources: SAM.gov notices and award notices; Senate LDA lobbying filings; FEC filings; FARA; Federal Register; congress.gov; SEC Form 4. Every row above links to its record.
Companies are matched to tickers by exact name only. A company we could not match shows no market rows; that is a miss, not a finding.